Construction and Application of Intelligent Warning Model Based on Evidence-Based Trajectory of DRG/DIP Disease Groups

China Health Insurance ›› 2024, Vol. 0 ›› Issue (8) : 67-72.

China Health Insurance ›› 2024, Vol. 0 ›› Issue (8) : 67-72. DOI: 10.19546/j.issn.1674-3830.2024.8.009
Special Topic Analysis

Construction and Application of Intelligent Warning Model Based on Evidence-Based Trajectory of DRG/DIP Disease Groups

Author information +
History +

Abstract

With the continuous advancement of the DRG/DIP medical insurance payment methods reform, new problems such as upcoded disease groups and cost transfer have emerged in medical insurance fund supervision. This paper deeply studied the innovative practice of Shanghai in DRG/DIP medical insurance intelligent supervision, and systematically demonstrated Shanghai's initial exploration of regulatory indicators and rule application to the construction of an intelligentwarning model based on evidence-based trajectory of disease groups. The warning model was embedded in the real supervision scenarios, the concept of clinical pathways was introduced, and big data plus AI technology was applied to detect suspicious points, the supervision personnel's dependence on medical professionals was reduced. The application of the intelligent warning model based on the evidence-based trajectory of DRG/DIP disease groups has effectively improved the scientificity, accuracy and efficiency of supervision. In the future, it is recommended to expand the scope of DRG/DIP intelligent supervision and warning, gradually optimize the evidence-based trajectory of disease groups, and continuously strengthen the hospitals' awareness of active supervision.

Key words

DRG / DIP / evidence-based trajectory / intelligent supervision

Cite this article

Download Citations
Construction and Application of Intelligent Warning Model Based on Evidence-Based Trajectory of DRG/DIP Disease Groups[J]. China Health Insurance. 2024, 0(8): 67-72 https://doi.org/10.19546/j.issn.1674-3830.2024.8.009

References

[1] 李乐乐,李怡璇.我国医保支付方式改革的治理路径分析——基于DRG与DIP的机制比较[J].卫生经济研究,2022,39(09):43-48.
[2] 黄蛟灵,耿韬,郭静.医药机构违法、违规使用医保基金原因分析及对策研究[M] //娄洪,应亚珍,郝春鹏.医保基金监管蓝皮书.北京:社会科学文献出版社,2023:122-134.
[3] 国务院办公厅.关于印发“十四五”全民医疗保障规划的通知[EB/OL].(2021-09-29)[2024-08-16].https://www.gov.cn/zhengce/zhengceku/2021-09/29/content_5639967.htm.
[4] 国家医疗保障局办公室.关于开展医保基金监管“两试点一示范”工作的通知[EB/OL].(2019-05-21)[2024-08-16].https://www.gov.cn/zhengce/zhengceku/2019-10/12/content_5438773.htm.
[5] 王坚强,王奕婷.DRG医保支付方式改革对医疗行为的影响[J].湖南社会科学,2021(01):133-139.
[6] 韩传恩. 公立医院绩效管理的实践与DRG应用探索[J].中国医院管理,2021,41(01):74-76.
[7] 张爱玲,谭华伟.DIP付费对医疗服务项目诊疗强度的影响研究[J].卫生经济研究,2024,41(07):41-43+48.
[8] 彭淑桢,易烨,林珂雯,等.临床路径的国内外发展现状分析[J].中华医院管理杂志,2023, 39(8):569-574.
[9] 王虎峰,赵阳,崔兆涵.医保支付方式由治病向健康转型——先期探讨研究[J].北京航空航天大学学报(社会科学版),2024,37(04):79-88.
[10] 徐庆峰,武启峰,赵晨,等.公立医院DRG病组成本—效益分析探索[J].中国卫生经济, 2022,41(08):83-88.
[11] 王浩宇,周典,周苑,等.DRG改革背景下我国公立医院控费提质研究[J].南京医科大学学报(社会科学版),2023,23(03):212-216+252.

Accesses

Citation

Detail

Sections
Recommended

/